243 related articles for article (PubMed ID: 2447569)
1. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
2. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
3. [Various aspects and results of therapy with interferon].
Niederle N
Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
[TBL] [Abstract][Full Text] [Related]
4. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
6. [Antineoplastic effects of interferons].
Shimoyama M
Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
[No Abstract] [Full Text] [Related]
7. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
8. [Status and trends in hematology].
Stobbe H
Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527
[No Abstract] [Full Text] [Related]
9. Recent developments in the treatment of hemopoietic and lymphoid neoplasms.
Flexner JM
J Tenn Med Assoc; 1977 Jan; 70(1):13-6. PubMed ID: 319299
[No Abstract] [Full Text] [Related]
10. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
11. Alfa interferon: combinations with other antineoplastic modalities.
Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
[TBL] [Abstract][Full Text] [Related]
12. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
13. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
14. [Study of some aspects of the problem of leukemias and bone marrow transplantation in France].
Faĭnshteĭn FE; Reshchikov VP
Probl Gematol Pereliv Krovi; 1977 Nov; (11):56-8. PubMed ID: 339227
[No Abstract] [Full Text] [Related]
15. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
Acta Haematol Pol; 1980; 11(3):165-71. PubMed ID: 6449819
[No Abstract] [Full Text] [Related]
16. Apheresis in hematologic and oncologic disease.
Cohen RJ
Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
[TBL] [Abstract][Full Text] [Related]
17. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
18. Interferons in oncology.
Woll PJ; Pettengell R
Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
[TBL] [Abstract][Full Text] [Related]
19. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
20. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
[Next] [New Search]